Essen, Germany — Evonik had sales of EUR 6.6bn the first half of 2019. This is 1% lower by than the same period in 2018. Adjusted EBITDA across the business rose 5.9%, and hit EUR 1.2bn in the first half of 2019.
Looking across Evonik, the company said that demand from the automotive and coatings industries was lower than in the period in 2018.
The company's nutrition and care business includes a wide range of products, such as polyurethane additives and animal feed additives. Its sales subsided by 1% between the first half of 2018 and 2019, to EUR 2.3 bn in the first half of 2019.
Lower selling prices and negative currency effects hit performance in this division.
Adjusted EBITDA in the division declined by 14% to EUR 370m the first half of 2019. This compares with EUR 431m the 2018 period.
The EBITDA number was hit by the costs of starting up an animal feed business in Singapore.